MN HF 4064
died on adjournmentCommissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.
Minnesota · 2025-2026 · lower
Quick answers
Did MN HF 4064 pass?
No. MN HF 4064 died when the 2025-2026 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-04-20): Author added Torkelson
What is MN HF 4064 about?
MN HF 4064 is a bill in the 2025-2026 titled “Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.”.
Who sponsors MN HF 4064?
Reyer is the primary sponsor of MN HF 4064, joined by 9 cosponsors.
- Introduced
- 2026-03-09
- Latest action
- 2026-04-20 — Author added Torkelson
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Reyerprimary
- Hollinscosponsor
- Mahamoudcosponsor
- Virnigcosponsor
- Bergcosponsor
- Nadeaucosponsor
- Freibergcosponsor
- Biermancosponsor
- Backercosponsor
- Torkelsoncosponsor
Committees
Not provided by source.
Action timeline
2026-03-09
Introduction and first reading, referred to Health Finance and Policy
introduction,referral-committee
2026-04-20
Author added Torkelson
Versions
- Introduction — 2026-03-06Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: SF 4189
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:48.331508Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MN&identifier=HF 4064. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.